Patent details
EP3999507 Title: IMIDAZO[4,5-C]PYRIDINE DERIVATIVES AS TOLL-LIKE RECEPTOR AGONSITS
Basic Information
- Publication number:
- EP3999507
- PCT Application Number:
- IB2020056605
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP207433574
- PCT Publication Number:
- WO2021009676
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- IMIDAZO[4,5-C]PYRIDINE DERIVATIVES AS TOLL-LIKE RECEPTOR AGONSITS
- French Title of Invention:
- DÉRIVÉS D'IMIDAZO [4,5-C] PYRIDINE EN TANT QU'AGONISTES DU RÉCEPTEUR DE TYPE TOLL
- German Title of Invention:
- IMIDAZO[4,5-C]PYRIDINDERIVATE ALS TOLL-LIKE-REZEPTORAGONISTEN
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 15/01/2025
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 21/01/2025
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 15/01/2025
- Unitary Effect Registration Date:
- 21/01/2025
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 14/07/2020
- Grant date:
- 15/01/2025
- EP Publication Date:
- 25/05/2022
- PCT Publication Date:
- 21/01/2021
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 15/01/2025
- EP B1 Publication Date:
- 15/01/2025
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 14/07/2040
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 08/01/2025
- Name:
- Pfizer Inc.
- Address:
- 66 Hudson Boulevard East, New York, NY 10001-2192, United States (US)
Inventor
1
- Name:
- ZHANG, Lei
- Address:
- United States (US)
2
- Name:
- UNWALLA, Rayomand J
- Address:
- United States (US)
3
- Name:
- LACHAPELLE, Erik Alphie
- Address:
- United States (US)
4
- Name:
- XIAO, Jun
- Address:
- United States (US)
5
- Name:
- AHMAD, Omar
- Address:
- United States (US)
6
- Name:
- FISHER, Ethan Lawrence
- Address:
- United States (US)
7
- Name:
- FENSOME, Andrew
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201962875465 P
- Priority Date:
- 17/07/2019
- Priority Country:
- United States (US)
2
- Priority Number:
- 202062961288 P
- Priority Date:
- 15/01/2020
- Priority Country:
- United States (US)
Classification
- IPC classification:
- C07D 471/04; A61P 35/00; A61K 31/437;
Publication
European Patent Bulletin
1
- Issue number:
- 202503
- Publication date:
- 15/01/2025
- Description:
- Grant (B1)
2
- Issue number:
- 202508
- Publication date:
- 19/02/2025
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202508
- Publication date:
- 19/02/2025
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|